Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
A phase 3 trial of Adaptive radiotherapy in Rectal cancer, run by Shandong Cancer Hospital and Institute, active and no longer recruiting.
Overview
Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer is a phase 3 interventional study registered as NCT06246344 by Shandong Cancer Hospital and Institute, with 128 participants planned, started 2023-12-01 and due to reach its primary completion in 2025-12-01. Interventions recorded: Online Adaptive Radiotherapy With Sequential Boost, Conventional Non-Adaptive IMRT, Capecitabine, CAPEOX, Total Mesorectal Excision. Conditions recorded: Rectal Cancer.
Linked to the technology Adaptive radiotherapy because the registry names it ("adaptive radiotherapy") among its interventions and Rectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialResponse Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
Shares Adaptive radiotherapy (online replanning) and the tag pipeline.
- TrialModerated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
Shares Adaptive radiotherapy (online replanning) and the tag pipeline.
- TrialMR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
Shares Rectal cancer, Capecitabine and the tag pipeline.
- TrialOrgan Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy
Shares Rectal cancer and the tag pipeline.
- TrialPreoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer
Shares Rectal cancer and the tag pipeline.
- TrialTo Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.
Shares Rectal cancer and the tag pipeline.
- TrialNCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC
Shares Rectal cancer and the tag pipeline.
- TrialStudy of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Shares Rectal cancer and the tag pipeline.